Secondary |
Drug Use For Unknown Indication |
11.9% |
Systemic Lupus Erythematosus |
11.9% |
Crohn's Disease |
9.5% |
Hiv Infection |
9.5% |
Myasthenia Gravis |
7.1% |
Hereditary Angioedema |
6.3% |
Blood Cholesterol Increased |
4.8% |
Ill-defined Disorder |
4.8% |
Lung Adenocarcinoma |
4.8% |
Rash |
4.8% |
Prophylaxis Against Transplant Rejection |
4.0% |
Keratitis Herpetic |
3.2% |
Product Used For Unknown Indication |
3.2% |
Arthralgia |
2.4% |
Back Pain |
2.4% |
Immunosuppressant Drug Therapy |
2.4% |
Immunosuppression |
2.4% |
Adverse Drug Reaction |
1.6% |
Asthma |
1.6% |
Cryptococcosis |
1.6% |
|
Weight Decreased |
14.7% |
Hepatosplenic T-cell Lymphoma |
11.8% |
Hepatitis B |
8.8% |
Condition Aggravated |
5.9% |
Erythema |
5.9% |
Neurotoxicity |
5.9% |
Rash Pruritic |
5.9% |
Weight Increased |
5.9% |
Adrenocortical Carcinoma |
2.9% |
Amnesia |
2.9% |
Chest Pain |
2.9% |
Cushing's Syndrome |
2.9% |
Drug Dependence |
2.9% |
Drug Ineffective |
2.9% |
Haemoglobin Decreased |
2.9% |
Headache |
2.9% |
Hepatitis |
2.9% |
Lymphoedema |
2.9% |
Macular Oedema |
2.9% |
Memory Impairment |
2.9% |
|
Concomitant |
Colorectal Cancer Metastatic |
41.4% |
Product Used For Unknown Indication |
5.6% |
Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iii |
4.9% |
Prophylaxis Against Transplant Rejection |
4.9% |
Breast Cancer |
4.3% |
Anxiety |
3.7% |
Multiple Sclerosis |
3.7% |
Dermatitis Atopic |
3.1% |
Multiple Myeloma |
3.1% |
Colon Cancer Metastatic |
2.5% |
Colorectal Cancer |
2.5% |
Drug Use For Unknown Indication |
2.5% |
Immunosuppression |
2.5% |
Neuralgia |
2.5% |
Oesophageal Squamous Cell Carcinoma |
2.5% |
Oesophageal Squamous Cell Carcinoma Stage Iv |
2.5% |
Rheumatoid Arthritis |
2.5% |
Heart Transplant |
1.9% |
Juvenile Arthritis |
1.9% |
Non-small Cell Lung Cancer |
1.9% |
|
Vomiting |
11.5% |
Weight Decreased |
11.5% |
White Blood Cell Count Decreased |
11.5% |
Metabolic Acidosis |
5.8% |
Metastatic Squamous Cell Carcinoma |
5.8% |
Neutropenia |
5.8% |
Pyrexia |
5.8% |
Anaemia |
3.8% |
Drug Ineffective For Unapproved Indication |
3.8% |
Focal Glomerulosclerosis |
3.8% |
Hypertension |
3.8% |
Pancytopenia |
3.8% |
Peripheral Ischaemia |
3.8% |
Sepsis |
3.8% |
Stomatitis |
3.8% |
Suicidal Ideation |
3.8% |
Acinetobacter Test Positive |
1.9% |
Asthma |
1.9% |
Blood Lactate Dehydrogenase Increased |
1.9% |
Blood Pressure Systolic Increased |
1.9% |
|